Based on this, we believed that TBHP treatment might enhance the nuclear translocation of the cytosolic ATF3 protein, further increasing the level of ATF3 in the nucleus, thereby mediating the pathological process of IDD by promoting the regulation of ATF3 and its target and downstream genes. The gene discussed is ATF3; the disease is intervertebral disk degenerative disorder.